FDA OK’s ivermectin use vs worm


The local Food and Drug Administration (FDA) has approved the use of ivermectin by humans against a certain type of parasitic worm.

The certificate pf product registration paves the way for the drug to be sold commercially, FDA Director-General Rolando Enrique G. Domingo told an online news briefing on Wednesday.

Lloyd Laboratories applied for the certificate for locally manufactured ivermectin as a drug against roundworm, he said. It was approved after the company submitted data on the quality and stability of the product.

Some doctors and politicians have been pushing for the use of ivermectin as a treatment for the coronavirus.

The Health department earlier said there was insufficient evidence to recommend the use of ivermectin against COVID-19. It added that only hospitals given a compassionate special permit could distribute the drug. —
Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top